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Abstract: Gene set enrichment analysis for analyzing large profiling and screening experiments 
can reveal unifying biological schemes based on previously accumulated knowledge represented 
as “gene sets”. Most of the existing implementations use a fixed fold-change or P value cutoff 
to generate regulated gene lists. However, the threshold selection in most cases is arbitrary, and 
has a significant effect on the test outcome and interpretation of the experiment. We developed 
a new gene set enrichment analysis method, ie, FDR-FET, which dynamically optimizes the 
threshold choice and improves the sensitivity and selectivity of gene set enrichment analysis. 
The procedure translates experimental results into a series of regulated gene lists at multiple 
false discovery rate (FDR) cutoffs, and computes the P value of the overrepresentation of a gene 
set using a Fisher’s exact test (FET) in each of these gene lists. The lowest P value is retained 
to represent the significance of the gene set. We also implemented improved methods to define 
a more relevant global reference set for the FET. We demonstrate the validity of the method 
using a published microarray study of three protease inhibitors of the human immunodeficiency 
virus and compare the results with those from other popular gene set enrichment analysis 
algorithms. Our results show that combining FDR with multiple cutoffs allows us to control 
the error while retaining genes that increase information content. We conclude that FDR-FET 
can selectively identify significant affected biological processes. Our method can be used for 
any user-generated gene list in the area of transcriptome, proteome, and other biological and 
scientific applications.
Keywords: gene set enrichment analysis, false discovery rate, Fisher’s exact test, microarray 
profiling, protease inhibitors
Introduction
Expression profiling analysis usually begins with the generation of gene lists ranked 
by fold-changes or P values. Interpretation of the gene lists can be facilitated by 
analytical approaches such as gene set enrichment analysis,1 which utilizes a priori 
constructed reference gene sets that groups genes by classifiers, such as biological 
function or chromosome location.2 This type of analysis can help to identify the 
underlying biological mechanisms and increase the statistical power by reducing the 
dimensionality of the problem.
The general framework and methodology of gene set enrichment analysis 
approaches have been thoroughly analyzed and discussed.2,3 These methods can be 
classified as either self-contained or competitive, based on the definition of the null 
hypothesis. A self-contained test compares a gene set with a fixed standard, and 
is not dependent on genes outside of the set. These methods make use of the raw Advances and Applications in Bioinformatics and Chemistry 2011:4 submit your manuscript | www.dovepress.com
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  expression data, and some of them are based on logistic 
regression models while others utilize Hotelling’s t2-tests or 
the more general multivariate analysis of variance models.4,5 
By contrast, a competitive test compares the differential 
expression of a gene set with that of its complement. Most 
of these methods examine whether regulated genes are over-
represented in a given gene set by a test of independence in 
a two-by-two contingency table, where the test statistic can 
be constructed based on χ2,   hypergeometric, or binomial 
distribution.6 A strict fold-change or P value cutoff is needed 
to obtain the regulated gene list, but the choice of the cutoff 
is often arbitrary and can have a significant influence on 
the test outcome and, subsequently, the interpretation of an 
experiment.7,8 Alternatively, methods that utilize the whole 
vector of P values or fold-changes have been developed.9,10 
For example, parametric analysis of gene-set enrichment 
(PAGE) implements a computationally efficient solution 
based on the central limit theorem to define an enrichment 
probability.10
Implementation
We have implemented a new gene set enrichment analysis 
method, FDR-FET, which was first described by Ji et al11 in a 
transcriptional profiling study of compound dose responses. 
The current implementation extends the original method 
and provides options to choose the reference set (ie, “gene 
universe”).
FDR-FET automatically optimizes the cutoff criterion 
for a gene list (L) under investigation using a false discov-
ery rate (FDR) procedure that employs a series of linearly 
increasing critical values12 and has been shown to control the 
FDR at prespecified levels for independent test statistics.13 
Rather than employing a single FDR criterion that would 
represent an arbitrary limitation of the analysis, we calculated 
a series of regulated gene lists (li , where li ⊂ L, 1 # I  # 35), 
  corresponding to FDR cutoff values of 1%–35% (default, or 
per user-specified) in 1% increments.
We denote the gene set collection as S. The overlap 
between li and a gene set s of interest (s ⊂ S) is examined 
using a Fisher’s exact test (FET). We utilize the right test 
that evaluates the significance of positive association between 
two lists, ie, an enrichment of elements of list A (eg, li) in list 
B (eg, s) or vice versa.14 For each s, there are as many as 35 
FETs to be performed by default, and the most significant 
P value is retained. This procedure is repeated for each gene 
set s in S.
We have implemented FDR-FET as a Perl module 
(Bio::FDR-FET) with C inline codes. The module expects 
that gene sets S consisting of gene identifiers and   associated 
classifiers, and gene list L consisting of unique gene 
  identifiers and associated P values from a study of interest. 
We also provide an executable program that uses this module 
and reads two input files containing these datasets. The Perl 
module will evaluate each gene set s and output detailed 
analysis information such as best P value, odds ratio, and 
the corresponding FDR cutoff, numbers in the contingency 
table, and genes in the overlap (between s and the li with 
the best P value). The C inline code of the Perl module is 
a slightly modified implementation of the FET code found 
in R15 that is based on an elegant computation of binomial 
coefficients.16 The test data in the module contains the Gene 
Ontology pathways and gene P values are used in the example 
in the next section.
Additional options are provided to deal more rigorously 
with the choice of reference set that has a major influence on 
the P value. We allow four options for the reference set, ie, 
genes in L (“genes”), union of genes in L and S (“union”), 
intersection of genes in L and S (“intersection”), and a user-
specified arbitrary number (“user”). In particular, the third 
choice excludes genes with unknown classification from 
being counted as negative matches, which may be an issue 
with P value calculations. Details of how to use the Perl 
module can be found by searching for ‘Bio::FdrFet’ in the 
CPAN search website (http://search.cpan.org/).
Results and discussion
Here we demonstrate the performance of FDR-FET from 
three perspectives. First, we assessed the selectivity and 
sensitivity of the method. Second, we compared FDR-FET 
with other gene set enrichment analysis methods. Because 
FDR-FET takes P values as input and does not differenti-
ate the directions of gene regulation, we chose two popular 
implementations of the same category, ie, a simple FET 
and PAGE. Third, we compared the results generated from 
  different reference set options.
In general, the sensitivity of gene set enrichment analysis 
can be improved by removal of background noise, which can 
have a strong impact on the FDR result through removing 
the bottom n percentile of low intensity probes or probes 
flagged as “absent”, or similar. Consolidation of probes 
onto the gene level is also recommended to improve inde-
pendence of measures, which is one assumption of FET.3 
For example, Affymetrix probe sets can be consolidated 
by associating each gene with the most significant P value 
among all probe sets for the gene. Alternatively, one can 
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shown to improve the precision and accuracy of microarray 
data analysis.17,18
We utilized a microarray dataset from a published study 
on the cellular effects of three human immunodeficiency virus 
(HIV) protease inhibitors.19 It is well known that patients 
taking protease inhibitor drugs to treat HIV-autoimmune 
deficiency syndrome often develop a lipodystrophy-like 
syndrome, including hyperlipidemia, peripheral lipoatrophy, 
and central fat accumulation.20 Parker et al19 have shown that 
protease inhibitors could induce gene expression changes 
indicative of dysregulation of lipid metabolism, endoplasmic 
reticulum stress, and metabolic disturbance. These results are 
consistent with clinical observations, and provide a basis for 
a molecular mechanism for the pathophysiology of protease 
inhibitor-induced lipodystrophy.
The probe set level expression data was generated using 
the MAS 5.0 algorithm with quantile normalization,21 and the 
20% lowest expressed probe sets were removed. A one-way 
analysis of variance with respect to the “drug treatment” factor 
was performed to generate the sorted gene list by P values. We 
utilized gene sets from both the Gene Ontology22 project and 
the Kyoto Encyclopedia of Genes and Genomes (KEGG).23
Validation of FDR-FeT
To demonstrate the sensitivity and selectivity of FDR-FET, we 
generated 1000 randomized gene lists while retaining the same 
set of P values from the analysis of variance. We ran FDR-
FET on each of these gene lists using reference set option 1 
(ie, “genes”) and maximal FDR at 35% for every gene set 
in KEGG. The 95th and 99th percentiles of the   negative log 
of P values were calculated for every gene set, and these 
values are found to center around 1.9 and 2.6, respectively 
(Figure 1). As expected, no gene set shows any large deviation 
from the others. By contrast, the P values   generated from the 
real dataset exhibit a nonuniform   distribution with only a few 
highly significant gene sets. Importantly, the top three gene 
sets with the largest separations from the 99th percentiles 
are the targets of HIV protease   inhibitors, ie, aminoacyl-
tRNA biosynthesis (KEGG:hsa00970),   biosynthesis of 
steroids (KEGG:hsa00100), and glycolysis/gluconeogenesis 
(KEGG:hsa00010).
Comparison of FDR-FeT  
with a simple FeT test
Many of the existing gene set enrichment analysis implemen-
tations are based on FET with a fixed P value or fold-change 
cutoff. To compare the performance of FDR-FET, which 
employs a flexible cutoff criterion, with that of a typical 
gene set enrichment analysis, we analyzed the regulated gene 
list generated with an arbitrary FDR cutoff (35%). Table 1 
contains the10 most significant gene set hits calculated by 
FDR-FET using reference set option 1 (ie, “genes”) and maxi-
mal FDR at 35%. This list includes all the established major 
targets of the HIV protease inhibitors (lipid metabolism, 
amino acid metabolism, gluconeogenesis, and endoplasmic 
reticulum). By contrast, when a single arbitrary FDR cutoff 
(35%) is used, the effect on gluconeogenesis associated 
with the pathophysiology of protease inhibitors is missed. 
Moreover, as depicted in Figure 2, the P values for three 
representative gene sets reach the maximal significance at 
different FDR cutoffs, demonstrating that the utilization of 
a flexible cutoff criterion indeed maximizes the signal to 
noise ratio of a gene list for individual gene sets.
Comparison of FDR-FeT with PAge
PAGE analysis was performed using the whole vector of P 
values from the one way analysis of variance as input. Because 
PAGE is based on the central limit theorem that requires gene 
sets to be sufficiently large, we only examined those gene sets 
with sizes $10. The negative log of P   values for three gene 
sets (ie, GO:0006418, GO:0004812, and KEGG:hsa00970) 
are set to 20 because they all have a P value of zero by PAGE 
analysis. Again, we could identify all the major targets of 
HIV protease inhibitors in the top 10 gene set hits from 
PAGE output (Appendix 1).   Interestingly, the results from 
FDR-FET and PAGE show high concordance, despite the 
fundamental difference in their underlining   methodologies 
(Figure 3). Using a gene set negative log P value cutoff of 3, 
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Figure 1 Performance assessment of FDR-FeT using simulated datasets. P values are 
calculated for gene sets from the Kegg for each of the 1000 randomized gene lists using 
FDR-FeT (with the option “genes” and maximal FDR 35%). The 95th (red, squares) 
and 99th (green, triangles) percentiles of the P values are calculated for each of the 
gene sets. gene sets are ordered by their P values calculated from the real dataset 
(blue, diamonds). The top three gene sets (highlighted in red circles) with the largest 
separations from the 99th percentiles are the targets of human immunodeficiency 
virus protease inhibitors, ie, aminoacyl-tRNA biosynthesis (Kegg:hsa00970), steroid 
biosynthesis (Kegg:hsa00100), and glycolysis/gluconeogenesis (Kegg:hsa00010). 
Abbreviations: FDR, multiple false discovery rate; FeT, Fisher’s exact test; Kegg, 
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PAGE identified 76 significant affected gene sets, whereas 
FDR-FET identified 79, among which 63 are shared between 
the two methods. In particular, the two top 10 hit lists have 
eight gene sets in common.
Because PAGE is a parametric test, it is generally more 
liable to gene outliers. In other words, a gene (or a few 
genes) with a sufficiently large fold-change may lead to 
significant testing results for the gene set of which the gene 
is a member. For instance, GO:0008652 and GO:0000049 
have highly significant P values by PAGE, but only modest 
P values by FDR-FET (Figure 3). A close examination of 
the genes   annotated to these two gene sets reveals that both 
contain a couple of genes with extremely low P values from 
the analysis of variance test (Appendix 2). By contrast, genes 
in FET-based methods have equal weight, and the P value 
reflects the gene set enrichment in the regulated gene list, 
true to the name of gene set enrichment analysis. There are 
areas where FDR-FET and PAGE can complement each other. 
For example, FDR-FET is more robust when the gene set size 
is small and when PAGE cannot produce a reliable P value. On 
the other hand, incomplete gene annotation may affect FET-
based methods more than PAGE because lack of knowledge 
is counted as a “true negative” in the contingency table.
Comparison of different reference set 
options
When the biological experiment is performed using a focused 
gene array (ie, a subset of genes from a genome), the whole 
genome is used as the reference set, and the number of “true 
negative” is inflated, leading to unrealistic small P values in gene 
set enrichment analysis outputs. Therefore, one must evaluate 
what is (close to) the true “universe” for an enrichment analysis. 
We have introduced new options to address this issue:
•	 “Genes” whereby all genes tested are counted in the gene 
set enrichment analysis calculation, assuming that the gene 
sets are universally representing the genome universe
•	 “Intersection” can be used when the gene sets are selected 
to represent a restricted universe, eg, signaling pathways; 
in this case, only genes that are present in at least one of 
the signaling pathways are counted
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Figure 2 The impact of cutoff criterion on gene set analysis result. The influence of the FDR cutoff on the size of regulated gene list (bars, right axis) and on the significance 
of selected gene sets (calculated with the option “genes”) for the human immunodeficiency virus protease inhibitor experiment, ie, endoplasmic reticulum (GO:0005783; red, 
circles), lipid biosynthetic process (gO:0008610; green, triangles), and glycolysis/gluconeogenesis (Kegg:hsa00010; orange, diamonds). The highlighted data points indicate 
the maximal P values (labeled) for the respective hits in the gene sets. 
Abbreviations: FDR, multiple false discovery rate; Kegg, Kyoto Encyclopedia of Genes and Genomes; gO, gene ontology project.
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Figure 3. Comparison of the analysis result of FDR-FeT with that of PAge. P values 
are calculated for gene sets from the gene Ontology and Kegg for the human 
immunodeficiency virus protease inhibitor experiment using FDR-FET (with the 
option “genes” and maximal FDR 35%) and PAge (using the whole vector of gene 
P values as input). gene sets of size $10 are included in the plot. 
Abbreviations: FDR, multiple false discovery rate; FeT, Fisher’s exact test; Kegg, 
Kyoto Encyclopedia of Genes and Genomes; PAge, parametric analysis of gene-set 
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•	 “Union” represents the general case by which any genes 
are counted once they are present in either the regulated 
gene list or the gene sets (“genome as reference set”).
In options “genes” and “union”, annotated and   unannotated 
genes are both counted in the reference set, while in option 
“intersection”, genes are only counted when they are annotated 
in at least one of the gene sets. Table 2 contains the 10 most 
significant gene set hits by the option “genes” and the 
corresponding P values, and ranks by options “union” and 
“intersection” calculated using maximal FDR at 35%. All 
three options identified the main HIV protease inhibitor targets, 
present in the top 10 s, except for gluconeogenesis, which is 
ranked 12th in results generated from the “union” option. Using 
a gene set negative log P value cutoff of 3, the options “genes” 
and “intersection” identified similar numbers of affected gene 
sets, 79 and 73, respectively, among which 71 gene sets are 
shared between the two hit lists. By contrast, the “union” option 
identified 96 gene sets, of which 21 are unique to this option and 
appear to be   nonspecific and unrelated to the drug effects upon 
close   examination,   suggesting a possible loss of selectivity with 
this option (Appendix 1). The effect of “intersection” becomes 
more apparent when smaller gene sets are used. The P values 
and the order of the hits are altered when considering smaller 
reference sets (Appendix 1 and Appendix 3). By selecting an 
appropriate reference set, we can enhance the sensitivity and 
selectivity and reduce the number of spurious hits.
Conclusion
In summary, the employment of FDR and multiple cutoffs 
provides statistical rigor with additional flexibility. The gene 
list size is dynamically adjusted so that genes that increase 
information content are retained, but the addition of noise 
is limited. This methodology can be applied to results from 
divergent experiments (eg, hit lists from expression profiling 
and proteomics studies) as often found in chemogenomics 
and systems biology approaches.
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Appendix 1
http://expertbioinfo.com/Papers/FDR_FET/FDR_FET_
Appendix1.xls
Appendix 2
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Appendix 3
Comparison of the negative log of the P values calculated 
with the option “Genes” and “Intersection”. Only pathways 
associated with KEGG metabolism were chosen for this 
example. With the “Genes” option, ~11,000 genes were 
considered for the FDR-FET analysis. With the “Intersection” 
option only ~1000 genes that are represented at least once in 
46 metabolism related pathways were considered.